• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Virtmed gains $43 million in second round of funding

Article

Virtmed gains $43 million in second round of fundingVirtmed has secured more than $43 million from investors in its second round of funding. Among the investors are eHealth Technology Fund, New Enterprise Associates, Frazier & Co., and the

Virtmed gains $43 million in second round of funding

Virtmed has secured more than $43 million from investors in its second round of funding. Among the investors are eHealth Technology Fund, New Enterprise Associates, Frazier & Co., and the venture arm of 3Com. Virtmed is a three-year-old Cambridge, MA, firm that is banking on the integration of wireless devices, Internet technologies, and existing healthcare information systems to give doctors and nurses access to patient and other data at the point of care.

Virtmed’s primary product is a thin-client server designed to sit on-site and direct data between existing databases and handheld devices. The firm has also developed online reporting functions to allow users to update patient charts remotely.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.